Curium

Curium is a significant player in the pharmaceutical and healthcare industries, dedicated to developing, manufacturing, and distributing radiopharmaceutical products. Established in 2017 and based in Paris, France, the company focuses on providing essential agents for both diagnosis and treatment. Its comprehensive product range includes generators, cold kits, hot products, and auxiliary items crucial for nuclear medicine. Curium's operations are geared towards delivering medical isotopes and radioactive tracers, vital for patient care in areas like cancer treatment and diagnostics, ensuring high standards of quality and safety. The company's strategic emphasis on innovation and patient well-being solidifies its position in advancing medical imaging and therapeutic solutions globally.

With a workforce of 1,000 to 5,000 employees and operations spanning 25 locations, Curium demonstrates considerable scale and reach. The company's operational footprint supports its mission to make radiopharmaceuticals accessible to patients worldwide. Its product development pipeline and manufacturing capabilities are designed to meet the complex demands of the healthcare sector, ensuring a consistent supply of critical medical supplies. For insights into the people driving these advancements, Meet Curium's team to learn more about their leadership and expertise.

Financially, Curium has secured substantial funding, including debt financing rounds totaling $265 million in 2020 and $335 million in 2022, underscoring investor confidence in its growth trajectory and market position. The company reported a revenue of $675.1M, reflecting its substantial market presence and operational success. Curium's strategic investments and financial health enable its continued expansion and commitment to serving the global healthcare community. Explore financial highlights for detailed performanceView more...